Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion

Obesity

Volumn 16, Issue 1, 2008, Pages 77-81

  Briatore, Lucia ^a   Salani, Barbara ^a   Andraghetti, Gabriella ^a   Danovaro, Cristina ^a   Sferrazzo, Elsa ^a   Scopinaro, Nicola ^a   Adami, Gian F ^a   Maggi, Davide ^a   Cordera, Renzo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BLOOD; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; OBESITY; WEIGHT LOSS;

EID: 39449109556     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.9     Document Type: Article

References (39)

1. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3-19.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787.
3. Knowler WC, Barrett-Connor E, Fowler SE et al. The Diabetes Prevention Program Research Group: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
4. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544.
5. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
6. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1737.
7. Scopinaro N, Marinari GM, Camerini GB, Papaia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005;28:2406-2411.
8. Mingrone G, DeGaetano A, Greco AV et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 1997;40:599-605.
9. Brunzell JD, Robertson RP, Lerner RL et al. Relationship between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976;42:222-229.
10. Highes TA, Gwynne JT, Switzer BR, Herbst C, White G. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am J Med 1984;77:7-17.
11. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003;52:1098-1103.
12. Guidone C, Manco M, Valera-Mora E et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006;55:2025-2031.
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 1997;20:1183-1197.
14. Scopinaro N, Adami GF, Marinari GM et al. Billopancreatic diversion. World J Surg 1998;22:936-946.
15. Alvarsson M, Wajngot A, Cerasi E, Efendic S. K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years. Diabetobgia 2005;48:2262-2268.
16. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
17. Salani B, Briatore L, Andreghetti G et al. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity (silver spring) 2006;14:1511-1514.
18. Mari A, Manco M, Guidone C et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 2006;49:2136-2143.
19. Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N. Long-term normalization of insulin sensitivity following blllopancreatic diversion for obesity. Int J Obes Relat Metab Disord 2004;28:671-673.
20. Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N. Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res 2003;113:217-221.
21. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1-11.
22. Scopinaro N. Marinari GM, Pretolesi F et al. Energy and nitrogen absorption after biliopancreatlc diversion. Obes Surg 2000;10:436-441.
23. Mingrone G, Rosa G, Di Rocco P et al. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-α reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord 2002;26:1165-1172.
24. Naslund E, Kral JG. Impact of gastric bypass surgery on gut hormones and glucose homeostasis in type 2 diabetes. Diabetes 2006;55:S92-S97.
25. Valverde I, Puente J, Martin-Duce A et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after blllopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg 2005;15:387-397.
26. Rubino F, Forgione A, Cummings DE et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741-749.
27. O'Rahilly SR Nugent Z, Rudenski AS et al. Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet 1986;2:360-364.
28. Pimenta W, Korytkowski M, Mitrakou A et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 1995;273:1855-1861.
29. Weyer C, Hanson K, Bogardus C, Pratley RE. Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight. Diabetobgia 2000;43:36-46.
30. Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J et al. Morbidly obese individuals with Impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg 2006;16:1179-1188.
31. Toschi E, Camastra S, Sironi AM et al. Effect of acute hyperglycemia on insulin secretion in humans. Diabetes 2002;51:S130-S133.
32. Vague P, Moulin JR The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Metabolism 1982;31:139-142.
33. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Koltermann OG. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985;34:222-234.
34. Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 2001;44:929-945.
35. Seufer J. Leptin effects on pancreatic β-cell gene expression and function. Diabetes 2004;53:S152-S158.
36. Winzell MS, Nogueiras R, Dieguez C, Ahren B. Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem Biophys Res Commun 2004;321:154-160.
37. Greco AV, Mingrone G, Giancaterini A et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002;51:144-151.
38. Ohtsubo K, Takamatsu S, Mnowa MT et al. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 2005;123:1307-1321.
39. Guldstrand M, Ahren B, Adamson U. Improved beta-cell function after standardized weight reduction in severely obese subjects. An J Physiol Endocrinol Metab 2003;284:E557-E565.